Showing results (71-80 of 164) with videos related to
Sort By:
Pageof 17
Mayo Clinic Proceedings|May 1, 1982
Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitisG L Davis, A J Czaja, A H Baggenstoss, et al.Thrombosis Research|July 1, 1983
Factor VIII complex in chronic renal failure: influence of protein C, fibrinolysis and diabetes mellitusM M Bern, D I Klumpar, W E Wheeler, et al.Gastroenterology|March 29, 2000
Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonrespondersD R Nelson, G Y Lauwers, J Y Lau, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|March 1, 1986
Physiological changes in hemostasis associated with acute exerciseM E Wheeler, G L Davis, W J Gillespie, et al.Journal of Agricultural Safety and Health|September 26, 2007
The integration of a telemental health service into rural primary medical careG L Davis, J G Boulger, J C Hovland, et al.Journal of Hepatology|February 1, 1993
Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infectionJ Y Lau, G L Davis, E Orito, et al.Hepatology (Baltimore, Md.)|July 10, 1998
Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis CD R Nelson, C G Marousis, T Ohno, et al.Journal of Medical Virology|September 1, 1994
Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infectionG K Lau, R Lesniewski, R G Johnson, et al.Gene|December 15, 1990
High-level synthesis of biologically active human plasminogen activator inhibitor type 1 (PAI-1) in Escherichia coliW P Sisk, G L Davis, D Kingsley, et al.Lancet (London, England)|April 2, 1994
Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitisJ W Fang, G L Bird, T Nakamura, et al.Pageof 17